🇺🇸 FDA
Patent

US 7396927

Process for preparation of rosuvastatin calcium

granted A61PA61P3/06

Quick answer

US patent 7396927 (Process for preparation of rosuvastatin calcium) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P3/06